Loading stock data…
ASPI
$5.15-0.11 (-2.09%)
Market ClosedLast close May 1
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ASP Isotopes Inc. in the Basic Materials sector is trading at $5.15. The stock is currently near its 52-week low of $3.92, remaining 30.8% below its 200-day moving average. Technical signals show neutral RSI of 51 and bullish MACD crossover, explaining why ASPI maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 51) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$5.15
Potential Upside
5%
Whystock Fair Value$5.41
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$13.00+152.4%
Range$11.00 – $15.00
Fundamentals
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels s...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$701.28M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.61
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-142.52%
Volume
Today's trading volume
2.78M
Recent News
ASP Isotopes (ASPI) Announces New Business Update
ASP Isotopes Inc. (NASDAQ:ASPI) is one of the 10 High Growth Chemical Stocks to Buy. ASP Isotopes Inc. (NASDAQ:ASPI) provided a business update on April 13, 2026, in which it announced that it is expecting the first commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 this year, marking 2026 as the company’s transition to scale. The […]
April 2026's Top Growth Companies With Strong Insider Ownership
Over the last 7 days, the United States market has risen by 3.1%, contributing to a substantial 27% climb over the past year, with earnings forecasted to grow by 16% annually. In such a robust market environment, growth companies with high insider ownership can be particularly attractive as they often indicate strong confidence from those closest to the business operations and future prospects.
ASP Isotopes Q4 Earnings Call Highlights
ASP Isotopes (NASDAQ:ASPI) outlined plans to begin commercial deliveries from multiple enrichment and production assets in 2026, positioning the company as it transitions from infrastructure buildout to product shipments across nuclear medicine, electronic gases, and helium and LNG, executives said
The Future of Uranium Enrichment is Being Developed Today
One critical step of the nuclear fuel chain, uranium enrichment, has long been a domestic vulnerability for the United States. Traditional gas-centrifuge technology has been the proven workhorse for decades, delivering low-enriched uranium (LEU) for today’s reactor fleet. Now, next-generation laser-based methods promise dramatically higher efficiency, lower energy use, smaller footprints, and faster deployment. The [...]
ASP Isotopes (ASPI) Balances HALEU Ambitions With Securities Suit Progression – What Does It Signal?
In March 2026, Quantum Leap Energy LLC, a wholly owned ASP Isotopes subsidiary, signed a non-binding MOU with a major U.S. nuclear power operator to explore supporting new U.S.-based facilities for producing HALEU, LEU+ and providing uranium conversion and deconversion services, while securities fraud claims against ASP Isotopes were allowed to proceed in U.S. federal court. This combination of a potential role in strengthening America’s domestic nuclear fuel supply chain and ongoing...